Literature DB >> 19273500

The biology of activin: recent advances in structure, regulation and function.

Yin Xia1, Alan L Schneyer.   

Abstract

Activin was discovered in the 1980s as a gonadal protein that stimulated FSH release from pituitary gonadotropes and was thought of as a reproductive hormone. In the ensuing decades, many additional activities of activin were described and it was found to be produced in a wide variety of cell types at nearly all stages of development. Its signaling and actions are regulated intracellularly and by extracellular antagonists. Over the past 5 years, a number of important advances have been made that clarify our understanding of the structural basis for signaling and regulation, as well as the biological roles of activin in stem cells, embryonic development and in adults. These include the crystallization of activin in complex with the activin type II receptor ActRIIB, or with the binding proteins follistatin and follistatin-like 3, as well as identification of activin's roles in gonadal sex development, follicle development, luteolysis, beta-cell proliferation and function in the islet, stem cell pluripotency and differentiation into different cell types and in immune cells. These advances are reviewed to provide perspective for future studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273500      PMCID: PMC2704481          DOI: 10.1677/JOE-08-0549

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  153 in total

1.  Follistatin: essential role for the N-terminal domain in activin binding and neutralization.

Authors:  Y Sidis; A L Schneyer; P M Sluss; L N Johnson; H T Keutmann
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

2.  Up-regulation of the expression of activins in the pancreatic duct by reduction of the beta-cell mass.

Authors:  You-Qing Zhang; Hui Zhang; Akito Maeshima; Hideyuki Kurihara; Jun-Ichiro Miyagawa; Toshiyuki Takeuchi; Itaru Kojima
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

3.  Proliferative phase sertoli cells display a developmentally regulated response to activin in vitro.

Authors:  Jeremy J Buzzard; Paul G Farnworth; David M De Kretser; Anne E O'Connor; Nigel G Wreford; John R Morrison
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

4.  Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells.

Authors:  Masahiro Abe; Yasumi Shintani; Yuzuru Eto; Kazuyo Harada; Masaaki Kosaka; Toshio Matsumoto
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

Review 5.  Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium.

Authors:  Corrine Welt; Yisrael Sidis; Henry Keutmann; Alan Schneyer
Journal:  Exp Biol Med (Maywood)       Date:  2002-10

6.  BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells.

Authors:  Stephen E Gould; Maria Day; Simon S Jones; Haimanti Dorai
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

7.  Human follistatin-related protein: a structural homologue of follistatin with nuclear localization.

Authors:  D V Tortoriello; Y Sidis; D A Holtzman; W E Holmes; A L Schneyer
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

Review 8.  Follistatin-related protein (FSRP): a new member of the follistatin gene family.

Authors:  A Schneyer; D Tortoriello; Y Sidis; H Keutmann; T Matsuzaki; W Holmes
Journal:  Mol Cell Endocrinol       Date:  2001-06-30       Impact factor: 4.102

9.  Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.

Authors:  Yisrael Sidis; Drew V Tortoriello; William E Holmes; Yang Pan; Henry T Keutmann; Alan L Schneyer
Journal:  Endocrinology       Date:  2002-05       Impact factor: 4.736

10.  Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway.

Authors:  Myung-Ja Lee; Chul Woo Yang; Dong Chan Jin; Yoon Sik Chang; Byung Kee Bang; Yong-Soo Kim
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

View more
  78 in total

1.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

2.  Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages.

Authors:  Yin Xia; Virna Cortez-Retamozo; Vera Niederkofler; Rishard Salie; Shanzhuo Chen; Tarek A Samad; Charles C Hong; Silvia Arber; Jatin M Vyas; Ralph Weissleder; Mikael J Pittet; Herbert Y Lin
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

Review 3.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

4.  A new compass for activin research--a triumph for systems biology.

Authors:  Heber C Nielsen; John S Torday
Journal:  Endocrinology       Date:  2011-10       Impact factor: 4.736

5.  Activin A is stimulated by tumor necrosis factor-alpha and modulates collagen gene expression in human amniotic cells.

Authors:  Y Abe; M Komatsubara; M Saito; M Toda; H Shinozaki; T Tamura; Y Kasahara; H Sedakata; T Minegishi
Journal:  J Endocrinol Invest       Date:  2013-02-04       Impact factor: 4.256

6.  Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.

Authors:  Nathan A Ungerleider; Lara M Bonomi; Melissa L Brown; Alan L Schneyer
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

7.  Translational profiles of medullary myofibroblasts during kidney fibrosis.

Authors:  Ivica Grgic; A Michaela Krautzberger; Andreas Hofmeister; Matthew Lalli; Derek P DiRocco; Susanne V Fleig; Jing Liu; Jeremy S Duffield; Andrew P McMahon; Bruce Aronow; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

8.  L6E9 myoblasts are deficient of myostatin and additional TGF-beta members are candidates to developmentally control their fiber formation.

Authors:  Stefania Rossi; Elena Stoppani; Massimiliano Gobbo; Anna Caroli; Alessandro Fanzani
Journal:  J Biomed Biotechnol       Date:  2010-04-13

9.  Transforming growth factor beta family expression at the bovine feto-maternal interface.

Authors:  Kumiko Sugawara; Keiichiro Kizaki; Chandana B Herath; Yoshihisa Hasegawa; Kazuyoshi Hashizume
Journal:  Reprod Biol Endocrinol       Date:  2010-10-15       Impact factor: 5.211

10.  Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease.

Authors:  Maria Semitekolou; Themis Alissafi; Maria Aggelakopoulou; Evangelia Kourepini; Harsha H Kariyawasam; Antony B Kay; Douglas S Robinson; Clare M Lloyd; Vily Panoutsakopoulou; Georgina Xanthou
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.